Many patients notice reduced appetite within the first few weeks
Laboratoriechef Pharma, Kosmetik & Helse, Biofac/1948 Clinical Supply Manager Senior Medical Specialist, Therapeutic Areas - Global Clinical Development Pharmacokineticist, PK/PD Modelling & Simulation Senior P&C Business Partner Medical Writer responsible for Clinical Disclosure Director, Drug Safety Operations
It is a solid clinical trial that directly demonstrates for the first time in a well-controlled intervention study that semaglutide (a GLP-1 receptor agonist) reduces alcohol consumption in patients undergoing treatment for alcohol use disorder and obesity
En este sentido, y respecto de las mejoras a nivel cognitivo, Cetkovich ejemplifica que "se trata de medicamentos que requieren la aplicacin diaria o semanal de una inyeccin subcutnea y esto, de por s, te est sealando una conducta que implica una mayor atencin sobre la salud , y esa sera una variable a controlar para ver cul es el factor que incide positivamente"